Xu Sheng Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xu Sheng Huang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
A.J. Liu
Department of Pathology, Chinese PLA General Hospital, Beijing, China
1 shared publicationC.J. Fu
Department of Stomatology, Chinese PLA General Hospital, Beijing, China
1 shared publicationC.Q. Pu
Department of Neurology, Chinese PLA General Hospital, 28 Fu Xing Road, Beijing 100853, China
1 shared publicationD. Wang
Department of Pathology; Chinese PLA General Hospital; Beijing; China
1 shared publicationD. Wei
PLA 309 Hospital; Beijing; China
1 shared publicationF. Cui
Department of Neurology; Chinese PLA General Hospital, Beijing China; Beijing; China
1 shared publication
Latest Publications
- 1 April 2013
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 128 (5) , 345-350
Lack of Epstein-Barr virus infection in Chinese myasthenia gravis patients
Objective There are three recent contradictory reports on the incidence of Epstein–Barr virus in the pathogenesis of myasthenia gravis, with all studies carried out in Caucasian patients. The current study evaluated whether Epstein–Barr virus infection had a role in the pathogenesis of myasthenia gravis in a cohort of 30 Chinese patients. Materials and methods Serial paraffin sections of thymic hyperplasia obtained from myasthenia gravis patients were analyzed for the presence of Epstein–Barr virus‐encoded small RNA ‐1 and Epstein–Barr virus latent membrane protein 1 by in situ hybridization and immunohistochemistry, respectively. Epstein–Barr virus+ cervical lymph nodes from lymphoma patients and Epstein–Barr virus‐ thymus specimens obtained during cardiac surgery served as the positive and negative control groups, respectively. Results All the 30 myasthenia gravis specimens were negative for both Epstein–Barr virus‐encoded small RNA ‐1 and Epstein–Barr virus latent membrane protein 1 tests. However, we obtained well‐characterized membrane and cytoplasmic immunohistochemical and in situ hybridization staining for both Epstein–Barr virus latent membrane protein 1 and Epstein–Barr virus‐encoded small RNA ‐1, respectively, in the positive control samples. Conclusions Our results therefore do not support a role of thymic Epstein–Barr virus infection in myasthenia gravis pathogenesis and calls for an integration of methodological and interpretation issues in detecting Epstein–Barr virus incidence in myasthenia gravis patients.
- 1 April 2013
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 128 (5) , 345-350
Lack of Epstein-Barr virus infection in Chinese myasthenia gravis patients
Objective There are three recent contradictory reports on the incidence of Epstein–Barr virus in the pathogenesis of myasthenia gravis, with all studies carried out in Caucasian patients. The current study evaluated whether Epstein–Barr virus infection had a role in the pathogenesis of myasthenia gravis in a cohort of 30 Chinese patients. Materials and methods Serial paraffin sections of thymic hyperplasia obtained from myasthenia gravis patients were analyzed for the presence of Epstein–Barr virus‐encoded small RNA ‐1 and Epstein–Barr virus latent membrane protein 1 by in situ hybridization and immunohistochemistry, respectively. Epstein–Barr virus+ cervical lymph nodes from lymphoma patients and Epstein–Barr virus‐ thymus specimens obtained during cardiac surgery served as the positive and negative control groups, respectively. Results All the 30 myasthenia gravis specimens were negative for both Epstein–Barr virus‐encoded small RNA ‐1 and Epstein–Barr virus latent membrane protein 1 tests. However, we obtained well‐characterized membrane and cytoplasmic immunohistochemical and in situ hybridization staining for both Epstein–Barr virus latent membrane protein 1 and Epstein–Barr virus‐encoded small RNA ‐1, respectively, in the positive control samples. Conclusions Our results therefore do not support a role of thymic Epstein–Barr virus infection in myasthenia gravis pathogenesis and calls for an integration of methodological and interpretation issues in detecting Epstein–Barr virus incidence in myasthenia gravis patients.
- 1 December 2011
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 18 (12) , 1608-1615
Meningoencephalitis or meningitis in relapsing polychondritis: Four case reports and a literature review
- 1 December 2011
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 18 (12) , 1608-1615
Meningoencephalitis or meningitis in relapsing polychondritis: Four case reports and a literature review
- 13 October 2011
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 365 (15) , e32
Myotonia of the Tongue
Images in Clinical Medicine from The New England Journal of Medicine — Myotonia of the Tongue
- 13 October 2011
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 365 (15) , e32
Myotonia of the Tongue
Images in Clinical Medicine from The New England Journal of Medicine — Myotonia of the Tongue